RUNX Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of RUNX Antibodies for investigating RUNX proteins in various biological processes. RUNX Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RUNX proteins function as transcription factors with pivotal roles in hematopoiesis, bone development, and gene expression regulation. Research has shown RUNX proteins are involved in various diseases, including cancer, making them important targets for therapeutic intervention. Understanding RUNX protein function and regulation provides key insights into developmental biology and disease mechanisms. RUNX monoclonal antibodies enable precise detection and characterization of RUNX protein expression patterns across different tissue types. Advanced research techniques supported by RUNX monoclonal antibodies help reveal molecular mechanisms in cell differentiation and development. Investigating RUNX protein interactions and modifications advances knowledge of cellular signaling pathways. Santa Cruz Biotechnology monoclonal antibodies for RUNX proteins support researchers worldwide in advancing scientific understanding of human health and disease.